CDK9 is a dependency in GATA-3 driven and MCL-1 independent T-cell Lymphomas
Chenguang Wang1, Suhaib Abdelrahman2, Xiangrong Geng2
1Department of Internal Medicine, Division of Hematology and Oncology, University of Michigan, Ann Arbor, MI, USA. wchengua@med.umich.edu.
Blood Cancer Journal
|November 27, 2025
Summary
The transcription factor GATA-3 drives T-cell lymphomas by activating cyclin-dependent kinase 9 (CDK9). Targeting CDK9 presents a novel therapeutic vulnerability in these aggressive cancers.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- GATA-binding protein 3 (GATA-3) is a transcription factor crucial for oncogenic programs in T-cell lymphomas.
- GATA-3-driven transcriptional programs, alongside genetic factors, enhance tumor cell growth, survival, and chemotherapy resistance.
Purpose of the Study:
- To investigate the role of cyclin-dependent kinase 9 (CDK9) in T-cell lymphomagenesis.
- To identify CDK9 as a potential therapeutic vulnerability in T-cell lymphomas.
Main Methods:
- Utilized complementary and orthogonal approaches to study CDK9.
- Investigated mechanisms of CDK9-mediated lymphomagenesis.
- Examined the interplay between GATA-3 and CDK9 in regulating gene transcription and ribosome biogenesis.
Main Results:
- CDK9 activation was found to regulate oncogenic transcriptional programs in aggressive T-cell lymphomas.
- Multiple mechanisms were identified where CDK9 promotes T-cell lymphomagenesis.
- A specific mechanism revealed GATA-3's role in promoting CDK9 activation at GATA-3 dependent loci.
- Novel roles for GATA-3 and CDK9 in regulating rRNA transcription and processing were discovered, collectively promoting ribosome biogenesis.
Conclusions:
- CDK9 represents a significant therapeutic vulnerability across diverse T-cell lymphomas.
- Targeting CDK9 offers a promising strategy for treating T-cell lymphomas, including those driven by GATA-3.
Related Concept Videos
02:34Inhibition of Cdk Activity
5.5K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
5.5K
02:15M-Cdk Drives Transition Into Mitosis
6.2K
Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
6.2K
02:39Positive Regulator Molecules
6.4K
Mitotic cell division results in daughter cells that exactly resemble the parent cell. However, errors in the DNA replication or distribution of genetic material may lead to genetic mutations that may be passed down to every new cell formed from the resulting abnormal cell. Propagation of such mutant cells is restricted through checkpoint mechanisms present at different stages of the cell cycle. These checkpoints involve regulator molecules that either promote or demote cell cycle events.
6.4K
00:50Anaphase Promoting Complex
3.3K
The stepwise destruction of specific proteins is necessary for the progression and completion of the cell cycle. Such proteins are ubiquitinated by ubiquitin ligases and then subsequently destroyed by the proteasome. The SCF (Skp1/Cullin/F-box) and the anaphase-promoting complex (APC) are two important ubiquitin ligases involved in cell cycle progression. While SCF is active throughout the cell cycle, APC gets activated during metaphase to anaphase transition. Cdc20 or Cdh1 binds to APC and...
3.3K
02:17Separation of Sister Chromatids
4.3K
At the transition from prophase to metaphase, there is a reduction in cohesion along the chromosomal arms, resulting in the resolution of sister chromatids. However, residual cohesin connections remain to hold the sister chromatids together until the transition from metaphase to anaphase. The residual connection prevents any premature separation of sister chromatids, blocking the risks of aneuploidy within the daughter cells.
At the onset of anaphase, separase, a proteolytic enzyme, is...
At the onset of anaphase, separase, a proteolytic enzyme, is...
4.3K
01:24Small GTPases - Ras and Rho
5.2K
Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
Three regulatory proteins control their activity:
5.2K